Säkerhet och effektivitet av vänster buntgrenarea stimulering kontra konventionell hjärtresynkroniseringsterapi i hjärtsvikt (SYNCHRONICITY)
This study will compare two different methods to pace the heart to treat heart failure including:
- The current standard method of implanting a pacing lead in a vein on the surface of the left lower chamber of the heart (left ventricle) to deliver heart failure therapy. This method is called Cardiac Resynchronization Therapy (CRT).
- The other method is using a lead implanted in the Left Bundle Branch Area (LBBA) of your heart. This method is called Left Bundle Branch Area Pacing or LBBAP. This lead is approved by the Food and Drug Administration (FDA) to be implanted in this area of the heart, but not to provide heart failure treatment.
Studieöversikt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Studietyp
Studietyp
Inskrivning (Beräknad)
Inskrivning
Fas
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
Studiekontakt
- Namn: Jacqueline Beaulieu
- Telefonnummer: 1-800-227-3422
- E-post: jacqueline.beaulieu@bsci.com
Studieorter
-
-
Alabama
-
Huntsville, Alabama, Förenta staterna, 35801
- Rekrytering
- Heart Center Research, LLC
-
Kontakt:
- John Jennings, Dr.
-
Huvudutredare:
- John Jennings, Dr.
-
Mobile, Alabama, Förenta staterna, 36608
- Rekrytering
- Mobile Infirmary Medical Center
-
Kontakt:
- Ernest Matthew Quin, Dr.
-
Huvudutredare:
- Ernest Matthew Quin, Dr.
-
-
Arizona
-
Phoenix, Arizona, Förenta staterna, 85054
- Rekrytering
- Mayo Clinic Phoenix
-
Kontakt:
- Mayank Sardana, MD
-
Huvudutredare:
- Mayank Sardana, MD
-
-
Arkansas
-
Jonesboro, Arkansas, Förenta staterna, 72401
- Rekrytering
- Arrhythmia Research Group
-
Kontakt:
- Devi Nair, Dr.
-
Huvudutredare:
- Devi Nair, Dr.
-
-
California
-
La Jolla, California, Förenta staterna, 92037
- Rekrytering
- Scripps Memorial Hospital
-
Kontakt:
- Nicolas Olson, MD
-
Huvudutredare:
- Nicolas Olson, MD
-
Los Angeles, California, Förenta staterna, 90048
- Rekrytering
- Cedars Sinai Medical Center
-
Huvudutredare:
- Ashkan Ehdaie, MD
-
Kontakt:
- Ashkan Ehdaie, MD
-
Oakland, California, Förenta staterna, 94609
- Rekrytering
- Alta Bates Summit Medical Center
-
Kontakt:
- Rajan Shah, Dr.
-
Huvudutredare:
- Rajan Shah, Dr.
-
Santa Monica, California, Förenta staterna, 90404
- Rekrytering
- Pacific Heart Institute
-
Kontakt:
- Stephen Tang, MD
-
Huvudutredare:
- Stephan Tang, MD
-
Torrance, California, Förenta staterna, 90505
- Rekrytering
- Torrance Medical Center
-
Huvudutredare:
- Gene Kim, MD
-
Kontakt:
- Gene Kim, MD
-
Ventura, California, Förenta staterna, 93003
- Rekrytering
- Cardiology Associates Medical Group, Inc.
-
Kontakt:
- Jonathan Dukes, Dr.
-
Huvudutredare:
- Jonathan Dukes, Dr.
-
-
District of Columbia
-
Washington D.C., District of Columbia, Förenta staterna, 20010
- Rekrytering
- Washington Hospital Center
-
Kontakt:
- Cyrus Hadadi, MD
-
Huvudutredare:
- Cyrus Hadadi, MD
-
-
Florida
-
Sarasota, Florida, Förenta staterna, 34239
- Rekrytering
- Sarasota Memorial Hospital
-
Kontakt:
- Antonio Moretta, Dr.
-
Huvudutredare:
- Antonio Moretta, Dr.
-
Tampa, Florida, Förenta staterna, 33613
- Rekrytering
- AdventHealth Tampa
-
Huvudutredare:
- Kenneth Yamamura, MD
-
Kontakt:
- Kenneth Yamamura, MD
-
-
Georgia
-
Atlanta, Georgia, Förenta staterna, 30309
- Rekrytering
- Piedmont Hospital
-
Kontakt:
- Kavita Krishnasamy, MD
-
Huvudutredare:
- Kavita Krishnasamy, MD
-
Atlanta, Georgia, Förenta staterna, 30322
- Rekrytering
- Emory University Hospital
-
Kontakt:
- Anand Shah, MD
-
Huvudutredare:
- Anand Shah, MD
-
-
Idaho
-
Meridian, Idaho, Förenta staterna, 83642
- Rekrytering
- St. Luke's Idaho Cardiology Associates
-
Kontakt:
- Justice Oranefo, MD
-
Huvudutredare:
- Justice Oranefo, MD
-
-
Illinois
-
Hinsdale, Illinois, Förenta staterna, 60521
- Rekrytering
- University of Chicago
-
Kontakt:
- Shrinath Yeshwant, MD
-
Huvudutredare:
- Shrinath Yeshwant, MD
-
Naperville, Illinois, Förenta staterna, 60540
- Indragen
- Midwest Cardiovascular Institute
-
-
Indiana
-
Indianapolis, Indiana, Förenta staterna, 46250
- Rekrytering
- Community Heart and Vascular Hospital
-
Kontakt:
- Krishna Malineni, MD
-
Huvudutredare:
- Krishna Malineni, MD
-
-
Iowa
-
Iowa City, Iowa, Förenta staterna, 52242
- Rekrytering
- University of Iowa Hospitals and Clinics
-
Huvudutredare:
- Paari Dominic, MD
-
Kontakt:
- Paari Dominic, MD
-
-
Kentucky
-
Louisville, Kentucky, Förenta staterna, 40207
- Rekrytering
- Baptist Hospital East Louisville
-
Huvudutredare:
- Kevin Parrott, MD
-
Kontakt:
- Kevin Parrott, MD
-
-
Massachusetts
-
Fall River, Massachusetts, Förenta staterna, 02720
- Rekrytering
- Southcoast Physicians Group
-
Kontakt:
- Arnoldas Giedrimas, MD
-
Huvudutredare:
- Arnoldas Giedrimas, MD
-
-
Michigan
-
Ann Arbor, Michigan, Förenta staterna, 48109
- Rekrytering
- University of Michigan Hospitals
-
Huvudutredare:
- Thomas Crawford, MD
-
Kontakt:
- Thomas Crawford, MD
-
Grand Rapids, Michigan, Förenta staterna, 49525
- Rekrytering
- Corewell Health
-
Kontakt:
- Jawad Wassim, MD
-
Huvudutredare:
- Jawad Wassim, MD
-
-
Minnesota
-
Duluth, Minnesota, Förenta staterna, 55805
- Indragen
- St. Mary's Duluth Clinic Regional Heart Center
-
Saint Cloud, Minnesota, Förenta staterna, 56303
- Indragen
- Centracare Heart and Vascular Center
-
-
New Jersey
-
Morristown, New Jersey, Förenta staterna, 07932
- Rekrytering
- Morristown Medical Center
-
Kontakt:
- Michael Katz, MD
-
Huvudutredare:
- Michael Katz, MD
-
-
New York
-
Albany, New York, Förenta staterna, 12211
- Rekrytering
- Capital Cardiology Associates
-
Kontakt:
- Rizwan Alimohammad, MD
-
Huvudutredare:
- Rizwan Alimohammad, MD
-
Flushing, New York, Förenta staterna, 11355
- Rekrytering
- New York Hospital Queens
-
Kontakt:
- Seth Goldbarg, Dr.
-
Huvudutredare:
- Seth Goldbarg, Dr.
-
New York, New York, Förenta staterna, 10021
- Rekrytering
- Weill Cornell Medical University
-
Kontakt:
- Jim Cheung, Dr.
-
Huvudutredare:
- Jim Cheung, Dr.
-
New York, New York, Förenta staterna, 14621
- Rekrytering
- Rochester General Hospital
-
Kontakt:
- Dmitry Chuprun, MD
-
Huvudutredare:
- Dmitry Chuprun, MD
-
Syracuse, New York, Förenta staterna, 13057
- Rekrytering
- SUNY-Upstate Medical University
-
Kontakt:
- Jorge Romero, MD
-
Huvudutredare:
- Jorge Romero, MD
-
-
North Carolina
-
Charlotte, North Carolina, Förenta staterna, 28204
- Rekrytering
- Sanger Heart and Vascular Institute
-
Kontakt:
- Navid Nafissi, MD
-
Huvudutredare:
- Navid Nafissi, MD
-
Durham, North Carolina, Förenta staterna, 27710
- Rekrytering
- Duke University Medical Center
-
Kontakt:
- Daniel Friedman, MD
-
Huvudutredare:
- Daniel Friedman, MD
-
-
Ohio
-
Columbus, Ohio, Förenta staterna, 43219
- Rekrytering
- Mount Carmel Health System
-
Kontakt:
- Kamel Addo, MD
-
Huvudutredare:
- Kamel Addo, MD
-
Columbus, Ohio, Förenta staterna, 43214
- Rekrytering
- OhioHealth Research and Innovation Institute-Riverside Methodist Hospital
-
Kontakt:
- Anish Amin, MD
-
Huvudutredare:
- Anish Amin, MD
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Förenta staterna, 19104
- Rekrytering
- Penn Presbyterian Medical Center
-
Kontakt:
- John Bullinga, MD
-
Huvudutredare:
- John Bullinga, MD
-
Wilkes-Barre, Pennsylvania, Förenta staterna, 18702
- Rekrytering
- Geisinger Wyoming Valley
-
Huvudutredare:
- Pugazhendhi Vijayaraman, MD
-
Kontakt:
- Pugazhendhi Vijayaraman, MD
-
-
South Dakota
-
Sioux Falls, South Dakota, Förenta staterna, 57108
- Rekrytering
- Avera Heart Hospital of South Dakota
-
Kontakt:
- Christopher Stanton, Dr.
-
Huvudutredare:
- Christopher Stanton, Dr.
-
-
Tennessee
-
Nashville, Tennessee, Förenta staterna, 37205
- Rekrytering
- St.Thomas Health
-
Kontakt:
- Ricardo Lugo, MD
-
Huvudutredare:
- Ricardo Lugo, MD
-
-
Texas
-
Plano, Texas, Förenta staterna, 75093
- Rekrytering
- Heart Hospital Baylor Plano
-
Kontakt:
- Mustafa Dohadwala, MD
-
Huvudutredare:
- Mustafa Dohadwala, MD
-
Tyler, Texas, Förenta staterna, 75701
- Rekrytering
- Christus Trinity Mother Frances Health System
-
Kontakt:
- Stanislov Weiner, Dr.
-
Huvudutredare:
- Stanislov Weiner, Dr.
-
-
Virginia
-
Charlottesville, Virginia, Förenta staterna, 22908
- Rekrytering
- University of Virginia Medical Center
-
Huvudutredare:
- Pamela Mason, MD
-
Kontakt:
- Pamela Mason, MD
-
-
Deltagandekriterier
Urvalskriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
-
Patient is age 18 years or above, or of legal age to give informed consent specific to state and national law
-
Patient meets a guideline-based indication for a de novo CRT-D device
-
Primary prevention indication for ICD therapy
-
Ischemic or nonischemic cardiomyopathy with LVEF ≤ 35% within 6 months of enrollment (LVEF must be assessed after the subject has been on GDMT for a minimum of 3 months) using an appropriate method of assessment (i.e. Echo, MRI, etc)
-
NYHA class II-IV despite maximally tolerated guideline directed medical therapy (GDMT)* for at least 3 months
*GDMT is defined as all four drug classes listed below for at least 3 months prior to enrollment unless the investigator provides justification (e.g., contraindicated, not tolerated or cost): Renin Angiotensin System Inhibitors (ACE, ARB, or ARNI) Evidence based betablockers (metoprolol succinate, carvedilol, bisoprolol) Mineralocorticoid antagonists SGLT2 Inhibitor medications
-
Sinus rhythm with left bundle branch block (LBBB) defined as a QRS ≥ 140 ms in men and ≥ 130 ms in women with a predominantly negative deflection (QS or rS in lead V1 and mid QRS notching or slurring in at least two of the following leads: 1, aVL, V1, V2, V5, V6) within 3 months of enrollment
-
Patient is willing to participate in LATITUDE™ NXT remote patient monitoring
-
Patient is willing and capable of providing informed consent and participating in all testing associated with this investigation at an approved study site and at the protocol defined intervals (Note: Use of a legally authorized representative (LAR) is not allowed)
-
Patient plans to remain geographically stable (not permanently moving to another location) and can commit to all study participation requirements (procedure, follow-up visits and testing requirements)
Exclusion Criteria:
- Persistent or permanent atrial fibrillation (AF) within 3 months prior to enrollment and documented in the medical record
- Frequent premature ventricular contractions (PVCs), atrial arrhythmias, and/or other causes of expected percentage of cardiac physiologic pacing (CPP) delivery below 95% at the time of enrollment
- Non-LBBB conduction abnormalities (including right bundle branch block (RBB) or intraventricular conduction delay (IVCD)) within 3 months prior to enrollment
- Complete, second degree or high degree atrioventricular (AV) block, that requires pacing at the time of enrollment
- Current or prior pacemaker, ICD or CRT implant (Also includes non-transvenous ICD technology and leadless pacemakers)
- Prior or planned mechanical or bioprosthetic tricuspid valve replacement
- Currently receiving or previously received positive inotrope therapy within 3 months prior to enrollment
- Unstable angina, acute myocardial infarction, coronary artery bypass grafting, or percutaneous coronary intervention within 3 months prior to enrollment
- History of heart transplantation or left ventricular assist device (LVAD) implantation
- Less than 1 year of life expectancy at the time of enrollment
- Anticipated heart transplantation or LVAD implantation within 1 year of enrollment
- History of ventricular septal defect (VSD)
- Complex congenital heart disease
- Documented diagnosis of cardiac amyloidosis
- Known occlusion or other reason limiting central venous access for transvenous leads
- Women of childbearing potential who are, or plan to become, pregnant during the course of the study (assessment per investigator's discretion)
- Patient currently requiring dialysis
- Patient with known or suspected sensitivity to Dexamethasone Acetate (DXA)
- Patient with contrast dye allergy or unwilling/able to undergo pre-treatment with steroids and/or diphenhydramine
- Inability or refusal to comply with the follow-up schedule including subject living at such a distance from the investigational site that attending follow-up visits would be unusually difficult or burdensome
- Patient is enrolled in any other concurrent study. Co-enrollment into other studies such as observational studies/registries needs prior written approval by BSC. Local mandatory governmental registries are accepted for co-enrollment without approval by BSC.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Antal vapen
Vapen och interventioner
Deltagargrupp / ArmDeltagargrupp / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Aktiv komparator: CRT Cohort
Participants will be randomized, implanted with a BSC CRT-D device using a Quadripolar lead, and device programmed to the respective cohort. |
Participants randomized to this cohort will receive a BSC system: CRT-D, Right Atrial Lead (RA), Defibrillation Lead (RV), Quadripolar LV Lead. |
|
Experimentell: LBBA Cohort
Participants will be randomized, implanted with a BSC CRT-D using the INGEVITY+ pace/sense lead implanted in the LBBA, and device programmed to the respective cohort. |
Participants randomized to this cohort will receive a BSC system: CRT-D, Right Atrial Lead (RA), Defibrillation Lead (RV), INGEVITY+ pace/sense Lead (implanted in the LBBA) |
Vad mäter studien?
Primära resultatmått
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Composite of reduction in all-cause mortality, heart transplant, left ventricular assist device, heart failure events, ventricular tachycardia/ventricular fibrillation requiring device therapy or external defibrillation/cardioversion.
Tidsram: Through study completion, up to maximum of 5 years
|
The primary effectiveness endpoint is a composite of reduction in all-cause mortality, heart transplant, left ventricular assist device (LVAD), time to first heart failure (HF) events, time to first ventricular tachycardia (VT) / ventricular fibrillation (VF) requiring device therapy or external defibrillation/cardioversion. |
Through study completion, up to maximum of 5 years
|
|
System-related complication-free rate
Tidsram: 12 months
|
The primary safety endpoint is System-related complication-free rate of LBBAP at 12 months. This will be a single-arm analysis of the LBBAP group compared to a performance goal |
12 months
|
Sekundära resultatmått
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Win ratio composite assessment
Tidsram: Through study completion, up to a maximum of 5 years
|
Win Ratio Ranking: 1) Death 2) Heart Transplant/LVAD 3) Number of Heart Failure (HF) events (includes in-patient, out-patient and HF re-admission 4) Number of VT/VF episodes requiring device therapy or external defibrillation/cardioversion (one episode per 24 hours 5) Change in MLHFQ (Minnesota Living with Heart Failure Questionnaire) quality of life |
Through study completion, up to a maximum of 5 years
|
|
Composite of reduction in all-cause mortality, heart transplant, left ventricular assist device, heart failure events, ventricular tachycardia/ ventricular fibrillation requiring device therapy or external defibrillation/cardioversion.
Tidsram: Through study completion, up to a maximum of 5 years
|
The primary effectiveness endpoint is a composite of reduction in all-cause mortality, heart transplant, left ventricular assist device (LVAD), time to first heart failure (HF) events, time to first ventricular tachycardia (VT) / ventricular fibrillation (VF) requiring device therapy or external defibrillation/cardioversion. |
Through study completion, up to a maximum of 5 years
|
|
System-related complication-free rate between randomized arms
Tidsram: 12 months
|
System-related complication-free rate of LBBAP at 12 months. This will compare the two randomized arms. |
12 months
|
Samarbetspartners och utredare
Sponsor
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Studiestart
Primärt slutförande (Beräknad)
Primärt slutförande
Avslutad studie (Beräknad)
Avslutad studie
Studieregistreringsdatum
Först inskickad
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Första postat
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste uppdatering publicerad
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
Andra studie-ID-nummer
- C2403
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .